A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer.


Updates from The Motley Fool

Latest updates on MannKind from Fool.com.


Stock Performance

MNKD vs. S&P 500 | 2 Year Performance
View Interactive MNKD Charts
Sponsored by

Key Data Points

Primary metrics and data points about MannKind.
Current Price: $0.62
Prev Close: $0.60
Open: $0.58
Bid: $0.60
Ask: $0.62
Day's Range: $0.57 - $0.63
52wk Range: $0.55 - $3.79
Volume: 3,928,339
Avg Vol 4,417,194
Market Cap: $254M
P/E (ttm): -0.68
EPS (ttm): ($0.88)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about MannKind.
CAPS Rating 1 out of 5
 
697 Outperform
140 Underperform
CAPS All Stars
 
83 Outperform
40 Underperform

How do you think MannKind will perform against the market?



You pick for MannKind is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Matthew J. Pfeffer, CEO

0% Approve

Based on 0 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for MannKind.

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers